by EPHA | May 31, 2018 | Opinion
By Rose Gallagher, MBE, Professional Lead Infection Prevention and Control and AMR, Royal College of Nursing, EPHA Scientific Advisor on AMR Last month a headline in the UK media, “World’s worst’ super-gonorrhoea man cured, took my attention. I am used to seeing...
by EPHA | May 31, 2018 | Opinion
By Leonie Eilers, Policy Assistant, EPHA On 3 May 2018, the Dutch Permanent Representation to the EU, together with the United Kingdom and Sweden, hosted a roundtable discussion on the role of prevention in the fight against antimicrobial resistance (AMR). Katrina...
by European Public Health Alliance | May 17, 2018 | Statements
Brussels 17 May 2018 The signatories urge European policymakers to ensure that Europe’s response to the threat posed by the presence of pharmaceuticals in the environment (PiE) is taken seriously, and that present and future European action will be timely, resolute...
by European Public Health Alliance | Mar 14, 2018 | Opinion
Following its delivery at the European Commission’s Health Policy Platform on 27 November 2017, the EPHA-led Joint Statement and Call to Action on Antimicrobial Resistance (AMR), supporting and improving the implementation of the EU One Health Action Plan against...
by European Public Health Alliance | Mar 14, 2018 | Opinion
On 30 January, EPHA organised an event at the European Parliament, together with Changing Markets Foundation and the European Environmental Bureau, to discuss synergies between the available policy measures for tackling pharmaceuticals in the environment (PiE) and...
